BioCardia Analyst Price Targets - Benzinga

BioCardia Inc

BCDANASDAQ

Trade with Public

Trade with Public

$1.02

-0.02-1.92%

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

BioCardia Analyst Price Targets - Benzinga

BioCardia Analyst Price Targets

Wall Street analyst price targets and consensus rating for BioCardia (BCDA).

Price Target Range — 7 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$25Upside to Avg. PT+2375.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 24, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Jun 9, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Sep 22, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Dec 18, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Nov 14, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Oct 28, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Aug 21, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Aug 16, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4→$25
Jul 26, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
May 29, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Nov 14, 2023	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk